It’s taken too long!
... or why an investment in this MedTech innovator is worth its weight in gold.
September 29 2026
The journey of just one MedTech business that has survived Covid, rebuilt and relaunched.
It may have taken a long time, but an SME that has overcome curveballs, hurdles and sheer bad luck while protecting its shareholders, is worth its weight in gold.